Abstract. Human chorionic gonadotropin (hCG) is a member of a family of heterodimeric glycoprotein hormones that have a common ct subunit but differ in their hormone-specific 13 subunit. Site-directed mutagenesis of the two asparagine-linked glycosylation sites of hCGct was used to study the function of the individual oligosaccharide chains in secretion and subunit assembly. Expression vectors for the ~t genes (wild-type and mutant) and the hCG[3 gene were constructed and transfected into Chinese hamster ovary cells. Loss of the oligosaccharide at position 78 causes the mutant subunit to be degraded quickly and <20% is secreted. However, the presence of hCG[3 stabilizes this mutant and allows ~45% of the subunit in the form of a dimer to exit the cell. Absence of carbohydrate at asparagine 52 does not perturb the stability or transport of the ct subunit but does affect dimer secretion; under conditions where this mutant or hCGI3 was in excess, <30% is secreted in the form of a dimer. Mutagenesis of both glycosylation sites affects monomer and dimer secretion but at levels intermediate between the single-site mutants. We conclude that there are site-specific functions of the hCGct asparaginelinked oligosaccharides with respect to the stability and assembly of hCG.
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H
UMAN chorionic gonadotropin (hCG) ~ is a member of the glycoprotein hormone family which includes lutropin, follitropin, and thyrotropin. These hormones are heterodimers consisting of an ct subunit that is common among the four hormones, and a 13 subunit that gives each its unique biological activity (5, 36, 53) . The hCGa subunit contains two asparagine (Asn)-linked oligosaccharide chains (13, 23) , whereas the hCG13 subunit contains two Asn-linked and four serine O-linked carbohydrate units (3, 22, 24) .
Several studies have addressed the role of the Asn-linked oligosaccharide chains on the gonadotropins. Chemical or enzymatic methods have been used to remove all or part of the oligosaccharide chains to obtain a better understanding of carbohydrate function. While desialylation of hCG causes it to be rapidly cleared via the hepatic route (32) , its effects on biological activity in vitro are not clear (1, 33, 51) . Removal of carbohydrate internal to sialic acid or complete deglycosylation converts hCG into an antagonist; it binds more tightly to its receptor, but shows decreased biological activity in vitro (6, 21, 25, 33) . Although the role of the oligosaccharide side-chains in folding and assembly of the hCG subunits in vivo is unknown, it has been postulated that 1 . Abbreviations used in this paper: Asn, asparagine; CHO. Chinese hamster ovary; Endo F, Endoglycosidase F; Endo H, Endoglycosidase H; hCG, human chorionic gonadotropin; Thr, threonine. these oligosaccharides are important for correct disulfide bond formation (48) . Combination of hCG subunits apparently occurs when the oligosaccharides are removed chemically (21, 25) or enzymatically (16) . However, one problem with these methods is that incompletely deglycosylated derivatives are generated; in addition, such procedures can cause denaturation and/or dissociation of the subunits, and therefore alter the hormone in other ways not related to carbohydrate removal.
The most common method to prevent Asn-linked glycosylation is with tunicamycin which blocks the synthesis of the lipid-carbohydrate carrier complex (49) . The problems with this approach are that individual carbohydrate units on a multiglycosylated protein cannot be examined, and indirect effects of tunicamycin could affect secretion of the glycoprotein. We have used oligonucleotide-directed mutagenesis to investigate the role of the individual Asn-linked oligosaccharides on hCGct in secretion and assembly in vivo. Using DNA-mediated transfer techniques, we have transfected vectors containing wild-type and mutant hCG~t genes into Chinese hamster ovary (CHO) cells and selected lines expressing the various subunits. We have also co-transfected the hCG13 construct with the wild-type and mutant hCGa genes to examine assembly in vivo. Using site-directed mutagenesis of the hCGct glycosylation sites, removal of a single oligosaccharide enhances degradation whereas loss of the other oligosaccharide alters the secretion of dimer. The loss of both oligosaccharides affects both secretion and dimerization but at intermediate levels between the single-site mutants. We conclude that there are site-specific intracellular functions of the two Asn-linked oligosaccharide chains on hCGct.
Materials and Methods
Enzymes used to prepare vectors were purchased from New England Biolabs, Beverly, MA; Bethesda Research Laboratories, Gaithersburg, MD; or Boehringer Mannheim Diagnostics, Inc., Houston, TX. Klenow fragment was a gift from Dr. John Majors, Washington University, St. Louis, MO. The DNA vector, MI3 UM20 (30), was obtained from International Biotechnologies, Inc., New Haven, CT. Oligonucleotides used for the sitedirected mutagenesis were prepared by the Washington University Sequencing Facility, St. Louis, MO. Cell culture media and reagents were prepared by the Washington University Center for Basic Cancer Research, St. Louis, MO. Dialyzed calf serum and the neomycin analogue, G418, were purchased from Gibco Laboratories, Grand Island, NY. FCS was purchased from rivatives, pM2aAAsnl, pM2ctAAsn2, pM-'ctAAsn(l+2), pM2~AThrl, pM2otAThr2, and pMZ0tAThr(l+2) were constructed by inserting BamBgl II fragments containing the wild-type hCGct (Fig. 1 A) and the mutant hCGct genes (not shown) into the compatible Barn H1 site in pM-'. The mutant genes were derived from mutagenesis of the hCGct fusion gene that had been inserted into M13 UM20 (see below).
Site-directed Mutagenesis
The Barn HI-Xho I fragment containing the hCGct fusion gene, as described in Fig. l , was ligated into M13 UM20 and the single-stranded viral recombinant DNA was isolated for mutagenesis. Mutant 22-met oligomers, 5'-GGTGACG'I~CTTTTGCACCAAC-3' and 5'-CTTAGTGGAGCGGGAT-ATG-3', were synthesized for mutagenesis of the Ash 52 and Ash TM codons, respectively; and mutant 26-mer oligomers, 5'-GTGGACTCTGAGGCC-ACGTTCTTTTG-3' and 5'-CAGTGGCACGCCGCATGGTTCTCCAC-3', were synthesized for mutagenesis of the corresponding Thr ~ and Thr 8~ codons, respectively. The mutagenesis procedure used was identical to that described by Seeburg et al. (44) except for the following modifications. The temperature of the annealing reaction was begun at 10~ above the calculated Tm and allowed to cool to 10~ below the Tm before placing the reaction on ice. The DNA synthesis reaction on the recombinant template was incubated overnight at 16~ followed by transformation of competent Escherichia coil K12 JMI09 cells. Hybridization and washing in tetramethylammonium chloride were as described in Wood et al. (55) ; the wash temperature for the 22-mers was 61~ and for the 26-mers was 67~ All mutant phage were further purified and rescreened to ensure that there was no wildtype phage contamination before sequencing. The integrity of the gene was rechecked by restriction enzyme analysis. The mutation frequency achieved was consistently >5%.
DNA Transfection and Clone Selection
Plasmids pM2CG0t, pM2aAAsnl, pM2aAAsn2, pM2aAAsn(l+2), pM2txAThrl, pM2aAThr2, and pM2aAThr(l+2) were transfected alone or co-transfected with pM~CG[3 into CHO cells by a modification of the calcium phosphate method (17, 35, 45) . Cells were selected for insertion of the plasmid DNA by growing in culture medium containing 0.25 mg/ml of the neomycin analogue, G418. Transfected colonies resistant to G418 were harvested ,-oll d after transfection and subsequently screened for the expression of hCGct (wild-type and mutant), or hCG dimer (wild-type and mutant) by immunoprecipitation of metabolically labeled cells (see below).
Cell Culture
The CHO cells were maintained in medium I (Ham's F12 medium supplemented with penicillin [100 U/ml], streptomycin [100 I.tg/ml], and glutamine [2 mM]) containing 5% (vol/vol) FCS at 37~ in a humidified 5% CO,_ incubator. Transfected clones were maintained in the above culture medium supplemented with 0.25 mg/ml active G418.
Metabolic Labeling
On day 0, cells were plated into 12-well dishes (350,000 cells/well) in l ml of medium I supplemented with 5% FCS. For continuous labeling experiments, cells were washed twice with cysteine-free medium II (medium I supplemented with 5% dialyzed calf serum) and labeled for 7 or 8 h in 1 ml of cysteine-free medium II containing 50 laCi/ml [sSS]cysteine (>l,000 Ci/mmol). For pulse-chase experiments, the cells were washed twice and preincubated for 1.5 h with cysteine-free medium II, followed by a 20-min pulse-labeling in cysteine-free medium II containing 100 laCi/ml [35S]cysteine. The labeled cells were then washed twice with medium II containing 1 mM unlabeled cysteine and incubated in this chase medium for the indicated times.
Immunoprecipitation
Medium and cell lysate samples were prepared, immunoprecipitated, and treated with endoglycosidases as described (10) . Polyclonal antisera against hCG0t and hCG[3 were prepared in our laboratory and were also a gift from Drs. Steven Birken and Robert Canfield, Columbia University College of Physicians and Surgeons, New York, NY. The antiserum used for each experiment is described in the text. Each antiserum had been titered and was added in severalfold excess to ensure complete immunoprecipitation.
PAGE
The hCGa, hCG[3, and hCG dimer immunoprecipitates were resolved on 15% SDS-polyacrylamide gels by the method of Laemmli (26) . Gels were soaked for 10 min in 1 M sodium salicylate, dried, and autoradiographed with preflashed film as described (10) . Autoradiographs were scanned with an Ultroscan XL laser densitometer (LKB Instruments, Inc., Gaithersburg, MD).
Results

Site-directed Mutagenesis of hCGa
The recognition signal for Asn-linked glycosylation of proteins is the tripeptide Asn-X-Thr/Ser (18, 19, 28) . The hCGa subunit contains two glycosylation sites at Asn 52 and 78. Oligonucleotide-directed mutagenesis (56) was chosen to examine the functional importance of the individual glycosylation sites in secretion and subunit assembly. Mutagenesis of either the Asn or the Thr amino acids in the Asn-X-Thr recognition sequence in the hCGa gene would be sufficient to prevent transfer of the carbodydrate to the a subunit (18, 19, 28) . We chose to convert the Ash to aspartic acid residues because they are isoterie and have similar hydrogen bond characteristics (see reference 31). The 5'-AAC-3' triplet coding for Asn 52 was converted to 5'-GAC-3' coding for aspartic acid (designated aAAsnl). A similar change was made at position 78 in a different clone (designated aAAsn2) and a third mutant gene was constructed in which both sites were mutated (designated ~tAAsn[l+2]). The Thr residues in these triplets were converted to alanine residues to assess that the results from the Ash mutants were due to loss of an oligosaccharide and not to alterations in the protein sequence (see reference 43). These mutants are designated 0tAThrl, uAThr2, and ctAThr(l+2) to denote changes of Thr 54, Thr s~ or both Thr's, respectively, to alanine residues. After mutant selections, we sequenced the mutated regions to verify that the changes were correct and that there were no other sequence alterations (Fig. 2 A) (42) . The wild-type (designated a-WT) and mutant hCGa proteins are depicted for ease of representation in Fig. 2 B. Construction of these mutants allowed us to examine the association of the individual hCGa Asnlinked oligosaccharides to the secretion, stability, and assembly of the intact dimer.
Expression of hCGa Glycosylation Mutants
To analyze the synthesis of the wild-type and mutant proteins, we inserted these genes into a eukaryotic expression vector, pM 2, and transfected the resultant plasmids into CHO cells. Stable clonal cell lines expressing ct-WT, aAAsnl, etAAsn2, and aAAsn(l+2) were isolated. These cell lines were labeled in the presence of [ssS]cysteine for 7 h, and media and cell lysate were analyzed for immunoprecipitable hCGet by SDS-PAGE (Fig. 3) . Except for aAAsn-(1+2), the intracellular ("lysate") hCGa forms migrated faster than the corresponding extracellular ("medium") form. This upward shift in molecular mass upon secretion of wildtype hCGa (intracellular, 23 kD; extracellular, 28 kD) is due to terminal processing of the Asn-linked chains on a-WT (data not shown) and is most likely responsible for the smaller shifts of the secreted forms of ctAAsnl (intracellular, 20 kD; extracellular, 22 kD) and ctAAsn2 (intracellular, 20 kD; extracellular, 23.5 kD). The change in molecular mass is not seen upon secretion of the mutant ctAAsn(1 +2) (15 kD) since it is devoid of Asn-linked oligosaccharides (data not shown).
Wild-type hCGct (ct-WT) is expressed at high levels and secreted very efficiently into the medium with severalfold more extracellular than intracellular material present, aAAsnl is also secreted in large amounts (with more material present in the medium than the lysate), but at a level lower than ct-WT. However, unlike ct-WT and ctAAsnl, ctAAsn2 and aAAsn(l+2) are not secreted into the medium in substantial amounts. Removal of the glycosylation sites and not the alteration in the amino acid is presumably responsible for these changes since the Thr~Alanine mutants give identical results (see below).
To document that the Asn-linked oligosaccharides on the secreted ct forms were complex in structure, and that the changes in the mobility of the mutated proteins were not due to proteolysis, we treated the wild-type and the two mutants, ctAAsnl and 0tAAsn2, with Endo H (50) and Endo F (12). Endo H cleaves high mannose, noncomplex, and hybrid-type oligosaccharides, whereas Endo F cleaves, in addition, complex oligosaccharides. Immunoprecipitable hCGot from the media of clones expressing ~t-WT, ~tAAsnl, and ~tAAsn2 was treated with Endo H or Endo F, and the products resolved on SDS-PAGE gels (Fig. 4) . Scanning densitometry revealed that <5 % of the a-WT, aAAsnl, and 0tAAsn2 were sensitive to Endo H. Wild-type and mutant material were completely sensitive to Endo F, and the digested material migrated at approximately the same molecular mass as deglycosylated wild-type ct (15 kD). Thus, >95% of the secreted material is resistant to Endo H but sensitive to Endo F, showing that the mutant and native subunits are processed to complex-type oligosaccharides and that their presence in the medium is due to passage through the normal secretory pathway and not due to cell lysis. Also, the Endo F data show that changes in mobility of the mutant subunits is due to the absence of oligosaccharide rather than proteolysis.
Secretion Kinetics of hCGa Mutants
As described above, the level of secretion of the mutants differed from wild-type 0t and could be attributed to lower 
on clones expressing ct-WT and the individual mutants (both Asn and Thr mutants). Confluent cells were pulse labeled with [35S]cysteine for 20 min, chased with unlabeled c3,steine for the indicated times, and the intracellular Clysate") and extracellular ("medium") hCGct forms were immunoprecipitated with a polyclonal hCGct-specific antiserum (Fig. 5) . In Fig. 5 A, the kinetics of disappearance of the intracellular ct-WT is the same as that seen for the appearance of ct-WT in the medium (t,/2 = 85 min). Scanning densitometry confirms that there is >95% recovery in the medium of a-WT. These results were comparable to pulse-chase studies of wild-type hCG0t secreted from C127 mouse mammary tumor cells transfected with hCGct (10) .
The pulse-chase kinetics of ctAAsnl (Fig. 5 B) and ctAThrl (Fig. 5 C) show identical rates of recovery from the cells, and their secretion into the medium (t,/~ = 85 min) was similar to wild-type hCGa (compare with Fig. 5 A) . Furthermore, >95 % of ctAAsnl and aAThrl accumulated in the medium but, unlike wild-type ct, these mutant subunits migrate at a more homogeneous position on the gel (see Discussion) and the secreted forms show less of an upward shift (only 2 kD). Thus, the absence of the oligosaccharide at Asn 52 by mutation of either the Asn or Thr residues does not affect either its secretion rate nor its recovery in the medium. Since ctAAsnl and ct-WT show no differences in secretion or degradation rates, the different secretion levels of aAAsnl and a-WT seen in Fig. 3 must be attributed to clonal variation in expression.
In contrast to the kinetics of aAAsnl, aAThrl, and ct-WT, mutagenesis of the second glycosylation site (ctAAsn2 and ctAThr2) markedly affects the behavior of the protein (Fig.  5, D and E) . Densitometric scanning of the autoradiograph indicates that the intracellular ctAAsn2 and ctAThr2 subunits disappear with similar kinetics as ct-WT, ctAAsnl, and ctAThrl (t,/,, = 80 rain). However, the amount recovered in the medium is much lower than aAAsnl, ctAThrl, Or ~t-WT; only 19 and 17% of the synthesized aAThr2 and t~AAsn2, respectively, are recovered. Thus, loss of carbohydrate at position 78 by either the Thr or Asn alteration affects the stability of the hCGct subunit resulting in an enhanced degradation rate. Moreover, in contrast to ~tAAsnl and ctAThrl, the extracellular form of t~AAsn2 and aAThr2 is heterogeneous like ct-WT (see Discussion).
The secretion kinetics of the deglycosylated mutants ctAAsn(l+2) and ctAThr(l+2) (Fig. 5, F and G) present a different pattern from that seen above. Unlike the fast disappearance from the cell of the wild-type or single mutated subunits, the double mutants are secreted from the cell very slowly (t~ = 6 h) and <50% can be recovered in the medium even after 10 h. We also examined the secretion kinetics of the wild-type ct from cells treated with tunicamycin, an inhibitor of N-linked glycosylation (Fig. 5 H) . In this case, as seen with double mutants, this deglycosylated r form is secreted slowly (t,/~ -~ 3 h) and it is also recovered quantitatively in the medium. Thus, both the tunicamycin deglycosylated et and the mutant ct subunits are slower to exit the cells; the small differences in the rates and extent of secretion may be due to indirect effects of tunicamycin on the cell or subtle effects of the amino acid substitutions. The media from each clone were divided into two aliquots and immunoprecipitated with hCGct or hCGI3 antisera. Electrophoresis and autoradiography were as described in Materials and Methods.
Assembly of hCGa Mutants with hCG[3
To examine subunit assembly of the wild-type hCG[~ subunit with hCGa and the various mutant hCGet subunits, pM2CGD (see Fig. 1 ) was co-transfected with pMECGa, single mutants, or double mutants. Clones expressing both subunits were then isolated and the ratio of hCGI3 to hCGa was determined by immunoprecipitation with either hCGaor hCGl3-specific antisera (Fig. 6) . For each mutant, we isolated some clones synthesizing excess hCGI3 subunit to ensure that the 13 subunit would not be limiting for dimer formation. Assembly of the various a forms with hCGI~ was assessed by immunoprecipitation with either an hCGa-specific antiserum which recognizes both free hCGot and dimer, or with hCGl3-specific antiserum which recognizes both hCGfl and hCG dimer. Since hCG~ is in excess, there should be equal amounts of a subunit precipitated by both antisera if complete dimerization has occurred.
Immunoprecipitation of wild-type hCG dimer with either a or 13 antiserum (Fig. 6, lanes 1 and 2) results in recovery of equal amounts of the a-WT subunit. This indicates that =100% of the a subunit is combined with the hCGI3 in the dimer form. In all clones isolated, hCGI~ exits as two forms which is due to the addition of one or two N-linked oligosaccharides (see reference 29). However, assembly of the glycosylation site I mutants (aAAsnl and ctAThrl) with the hCGI~ subunit is much less efficient. Although hCGI3 is severalfold in excess, <30% of the otAAsnl (clone 11-12, lanes 3 and 4) and <10% of the aAThrl (clone 6-5, lanes 7and 8) can assemble into dimers since the total amount of a secreted (lane 3 or 7) is greater than the dimer a (lane 4 or 8). Clone 6-14 (lanes 9 and I0) confirms that the lower amounts of assembly of the aAThrl mutant vs. the ctAAsnl mutant is not peculiar to only one clone hut is representative of all mutant r clones. Moreover, these data suggest that different amino acid replacements in this region appear to have a small affect unrelated to the absence of sugar. Even when a clone secretes much higher amounts of aAAsnl comparable to a-WT (clone 11-7, lanes 5 and 6), <10% of the hCGI~ is combined with this mutant or aAAsnl with hCGI~ (compare subunits in lanes 5 and 6). A similar situation is seen when a clone secreting high amounts of r is analyzed (data not shown). Absence of the oligosaccharide from position 52 seems to alter formation of hCG dimer even in the presence of excess 13 subunit which is unable to drive the dimerization reaction. Alternatively, loss of the oligosaccharide at this site may affect the stability of the a/fJ complex and cause intracellular dimer dissociation. In any case, the oligosaccharide at position 52 prevents secretion of intact hCG dimer by altering the assembly and/or stability of the dimer complex.
Analysis of clones secreting both hCGI~ and glycosylation site II mutants (r and r reveals that loss of the oligosaccharide of this position has no effect on combination. Equal amounts of the mutant subunits are immunoprecipitated by both the a and 13 antisera from clones 4-6 (lanes 11 and 12), [7] [8] [9] [10] (lanes 13 and 14) , and 7-17 (lanes 15 and 16) indicating that =100 % of the secreted a subunit is combined with hCGI3. Thus, even though loss of glycosylation site 78 causes increased degradation, it does not affect assembly with hCGI3.
Removal of both glycosylation sites from the a subunit (aAAsn[l+2] and r has an intermediate effect on assembly with hCGI~. Analysis of clone B-18 (lanes 17 and 18) reveals that =65% of the total ~tAAsn(l+2) secreted is in the form of dimer. Similarly, only =30% of the aAThr-(1+2) is secreted as dimer from clone 27-9 (lanes 19and 20).
These quantitative differences could be due to (a) the approximately twofold higher levels of hCG~l in clone 13-18 vs. clone 27-9, which could be driving more ~t to combine or Figure 5 . Kinetics of secretion of hCGa wild-type and Asn-glycosylation mutant subunits. CHO clones expressing ot-WT (A), aAAsnl (B), ctAThrl (C), 0tAAsn2 (D), aAThr2 (E), aAAsn(l+2) (F), aAThr(l+2) (G), and a-WT treated with tunicamycin (H) were pulse labeled for 20 min, chased for the indicated times in Medium III, immunoprecipitated with hCGct antiserum, and prepared as described in Materials and Methods. Tunicamycin (2 lag/ml) was present continuously in the preincubation, labeling, and chase media for the ct-WT cells shown in H. (b) minor alterations in the protein backbone, as seen with the ctAAsnl and aAThrl dimers discussed above. In both cases, though, the amount of hCG13 is severalfold in excess of the deglycosylated 0t mutants and is thus much higher than the ratio seen for wild-type (lanes 1 and 2) where =100% combination has occurred. Thus, removal of both oligosaccharides alters assembly but to a lesser degree than loss of the oligosaccharide chain at position 52 alone. Treatment of dimer-secreting cells with tunicamycin also prevents assembly of the deglycosylated subunits, although in this case, lack of combination may also be due to loss of the two glycosylation sites on hCGI3 and not to loss of the hCGa sites alone (data not shown).
Since ctAAsn2 and aAThr2 efficiently combine with hCG13, these clones were used to determine if the 13 subunit might stabilize or protect these mutant a subunits from degradation. Clones 4-6 (13/aAAsn2) and 7-10 (13/ctAThr2) were subjected to pulse-chase analysis as described above, and both media and cell iysate samples were immunoprecipitated with an a-specific antiserum (Fig. 7) . The disappearance of the intracellular forms of ctAAsn2 (Fig. 7 A, lysate) and aAThr2 (Fig. 7 B, lysate) was identical and rapid (t,/2 = 60 min). In both cases, hCG13 lacking its O-linked sugars is co-precipitated from the lysate with the mutant ct forms although at much lower levels (Fig. 7, A and B, lysate) . The appearance of the secreted aAAsn2 and aAThr2 (Fig. 7, A and B, medium) is similar (t,~ = 60 min), and is also accompanied by an equal amount of hCG[3 as seen in Fig. 6 . Unlike the secretion of free 0tAAsn2 and aAThr2 where <20% is secreted (Fig. 5, D and E) , the presence of hCGI3 allows secretion of 42 and 49 % of the synthesized ctAAsn2 and aAThr2, respectively. Thus, the hCGI3 stabilizes the site 78 mutants from degradation and allows greater than twofold more material to be secreted as dimer.
Discussion
Asn-linked oligosaccharides have been implicated in several physiologic functions, including the maintenance of intracellular stability, secretion, receptor binding and biological activity, and modulation of the plasma half-life (see references 2, 34). For gonadotropins, the role of the oligosaccharide chains in receptor binding and biological activity has been examined extensively using chemically or enzymatically treated hormone (1, 6, 21, 25, 33) . Site-directed mutagenesis is an effective method to study the oligosaccharide sites on multiglycosylated proteins since individual glycosylation sites may have different functions. Here we changed both the Asn and Thr residues of the two glycosylation consensus sequences of hCGc~. This control is critical in light of the findings of Santos-Aguado et al. (43) which show that different amino acid replacements in the glycosylation recognition sequence of HLA-A2 molecules, and not loss of carbohydrate, could affect secretion.
Site-directed mutagenesis was used to study the two Asnlinked oligosaccharides on hCGct and their intracellular role in the secretion of intact dimer. Mutagenesis of the Asnlinked oligosaccharide at position 52 (ctAAsnl and ttAThrl) did not affect the secretion of the mutant subunit; the kinetics of secretion and recovery in the medium of the monoglycosylated form was identical to wild-type hCGct. Mutagenesis of the oligosaccharide at position 78 (ctAAsn2 and r revealed that the subunit was rapidly degraded and <20% was secreted. Loss of this oligosaccharide may disrupt folding and/or disulfide bond formation, altering the stability of the peptide and rendering it more sensitive to proteases. Normally, the oligosaccharide at position 78 of a-WT is resistant to Endo F unless the subunit is denatured first (data not shown). Although we do not know the basis for this resistance, it is possible that the ct polypeptide folds around this oligosaccharide to prevent the endoglycosidase from acting. This oligosaccharide might then be an important structural feature of the ct subunit similar to immunoglobulin molecules where the single oligosaccharide has been visibly seen to lie in a groove and to play a major role in the interaction of the Fc and Fad regions (46) . An alternative explanation for this degradation is that removal of the carbohydrate unmasks some determinant that directs the position 78 mutants to another compartment (e.g., lysosomes) where it is degraded.
Removal of both glycosylation sites (ctAAsn[l+2] and r slows secretion fourfold but allows =50% of the completely deglycosylated subunits to be secreted. Although an additive effect might be expected upon removal of both glycosylation sites, an intermediate amount of material was secreted and at a slower rate. The data suggest an interdependence of sugar sites-the presence of only one oligosaccharide seems to affect the tertiary structure of the molecules more than no carbohydrate at all; differences in the folding of the single-site mutants (r and r vs. the double-site mutants might account for the differential sensitivity to proteolytic degradation. Because tunicamycin prevents addition of all carbohydrates to multiglycosylated proteins, it is incapable of revealing this type of interdependence. This interdependence is an interesting finding in light of the mutagenesis study of the multiglycosylated VSV G membrane protein (27) . The absence of the individual glycosylation sites of VSV G protein has no effect on the secretion (27) , whereas loss of both sites causes aggregation of the deglycosylated protein (15, 27) . Similarly, aggregation of the a double-site mutants might also account for the differential secretion rates of the single and double mutants but cannot explain the other differences. These findings for the r glycosylation mutants will be useful in understanding the role of the oligosaccharides on other multiglycosylated membrane and secretory proteins.
In pituitary and placenta, hCGa is secreted in excess of hCGI3. The uncombined a subunit is larger and more heterogeneous than dimer-derived a subunit (the form of r combined with I~) (7, 20, 39, 40) . Of major interest are the structural modifications responsible for the increased heterogeneity of free ct (a*). Corless et al. (9) have shown that in C127 cells transfected with hCGct this heterogeneity resides on the Asnlinked oligosaccharides and is not due to the presence of an O-linked oligosaccharide unit as seen in cultured choriocarcinoma cells (8) . The secreted ct-WT and the site 78 mutants from CHO cells are more heterogeneous, whereas the secreted site 52 mutants are very homogeneous (Fig. 5 ). This heterogeneity is also seen when the a-WT is secreted from CHO cells defective in O-linked glycosylation confirming that the heterogeneity resides on the N-linked oligosaccharides (data not shown). Although we cannot exclude the possibility that mutagenesis of one site can affect terminal processing of the other site, the data imply that the oligosaccharide at position 52 is likely responsible for ct* heterogeneity. These findings also suggest that the a oligosaccharides undergo site-specific carbohydrate processing.
In vivo assembly was analyzed by coexpression of the hCGct wild-type and mutant genes with the wild-type hCGI3 gene. Whereas >95 % of the secreted wild-type hCGct and site II mutant subunits combine with hCGI~, <30% of the site I mutants are secreted as dimer, and only =50% of the double mutants dimerize. Thus, loss of the oligosaccharide from position 52 alters assembly and/or stability of the complex. Since the double mutants are secreted slowly, they may have a greater chance of interacting with a 13 subunit, which accounts for the increased assembly compared to ctAAsnl and r Differences in folding between the single-and double-site mutants might also account for the variations seen; loss of carbohydrate at position 52 may perturb the folding of the mutant subunit, and thereby alter a/13 assembly without affecting proteolytic stability of this mutant. Alternatively, carbohydrate at position 52 may be present at the subunit/subunit interface and thus affect the interaction of the a and hCGI3 subunits. Previous studies have shown that carbohydrate-protein interactions are likely to be associated with subunit interactions for the neuraminidase tetramer of influenza virus (52) and the influenza hemagglutin trimer (54) where carbohydrate has been visualized at subunit interfaces.
In the presence of hCGIS, site II mutants are stabilized and secreted as intact dimer. After combination, hCGI3 might stabilize these mutants by blocking or altering a determinant that normally causes their degradation. Alternatively, hCGI3  may aid the folding of the ~t subunit. Gething et al. (14) have extensively analyzed the folding process in studies of the intracellular transport and assembly of influenza hemagglutinin molecules. Similar analyses will be critical in understanding (a) the role of hCGct oligosaccharides in the folding process and (b) why removal of each oligosaccharide does not have an additive effect on the stability and dimerization of the double mutants. Differences in folding of each mutant in the absence of carbohydrate could account for the variations in stability and assembly seen for these mutants.
These mutagenized forms of hCGa should also be useful for determining the association of specific oligosaccharides to biological activity of hCG. Sairam and Bhargavi (41) used chemical deglycosylation of bovine luteinizing hormone and follicle-stimulating hormone to examine the role of the oligosaccharides in the individual subunits. They showed that in contrast to the Asn-linked oligosaccharides on the 13 subunits, Asn-linked carbohydrates units on the ct subunit were more critical for biological activity. Only one of the two Asnlinked oligosaccharides on hCGa may be necessary for biological activity. That the two oligosaccharides have different intracellular functions (glycosylation site 78 plays a role in the integrity of the hormone, while site 52 is important for assembly of intact hCG molecules) suggests site-specific functions of the two oligosaccharides on hCGa. Whether this is a common feature of other secretory glycoproteins bearing multiple glycosylation sites, whether this feature is unique to hCGa, will require mutagenesis of other glycoproteins. 
